Interested in Making an Extra $10,000 Every month for Your Practice?
Modern Health Care Professional

Metagenics

Randomized Clinical Study Shows Ultra Glucose Control® in Combination with a Dietary Plan Results in a Significant Reduction in A1C Levels and Body Weight in Overweight and Obese Patients with Type 2 Diabetes

Study results presented at American Diabetes Association’s 76th Scientific Sessions

meta-tissueMetagenics,Inc., a lifestyle functional nutrition company, today announced novel clinical results of a randomized controlled research study that shows Ultra Glucose Control® Medical Food in combination with a dietary plan results in significant reduction in A1C levels and body weight in overweight and obese patients with Type 2 Diabetes compared to an individualized dietary plan alone. The study, conducted by the Joslin Diabetes Center, was presented yesterday at the American Diabetes Association’s 76th Scientific Sessions in New Orleans, Louisiana.

“Effective management of A1C levels, while challenging, is critical to

read more…

Metagenics Announces Collaboration with ReachMD for Evidence-Based Education on Clinical Nutrition for Healthcare Providers

221247LOGOMetagenics Healthcare Institute for Clinical Nutrition, MHICN, (www.mhicn.com), a peer-to-peer educational resource for all healthcare providers, announces an educational collaboration withReachMD®  to provide evidence based learnings in clinical nutrition and lifestyle medicine to improve patient management and reduce healthcare utilization. Online medical education is globally the fastest growing learning channel for today’s healthcare professionals, and MHICN and ReachMD are digital knowledge centers committed to being conduits for the exchange of technologic innovation, research data, and disruptive ideas on nutritional solutions for optimal patient outcomes. As noted by Metagenics Chief Science Officer, John Troup, PhD, “This unique read more…

Metagenics Unveils OmegaGenics® SPM Active, a Supplement for Tissue Health and Immune Response

meta-instiALISO VIEJO, Calif., Oct. 5, 2015 /PRNewswire-USNewswire/ – Metagenics, Inc., a nutrigenomics and lifestyle medicine company focused on improving health, today announced the launch of OmegaGenics SPM Active, a first-in-class nutritional supplement with specialized pro-resolving mediators (SPMs) designed to help support the resolution of the immune response—a natural response to tissue challenges from cellular damage, unhealthy diets and lifestyles. SPM production in the body decreases with age so SPM Active is particularly supportive of healthy aging.

When tissues in the body are challenged, the body reacts by developing a tailored immune response by recruiting cells and clearing cellular debris read more…

Metagenics Announces Partnership for Precision Biotic Research and Product Use

Metagenics Healthcare Institute for Clinical Nutrition announced exclusive licensing rights to the targeted probiotic, Lactobacillus salivarius subsp. salivarius UCC118 from Alimentary Health and University College Cork, Cork, Ireland. Probiotics are live microorganisms found naturally in the body and UCC118 is a specialized probiotic also known as a “precision biotic” as it offers a targeted solution to support intestinal function including support of intestinal permeability.

Mounting scientific and clinical evidence, as seen in the current New York Times, is revealing specific probiotics influence targeted aspects of health outcomes ranging from influence of metabolic conditions to the gut brain axis including read more…

Osama Hamdy, MD PhD, Presented Results of Metagenics’ Ultra Glucose Control™ on Glucose Response and GLP-1 at ADA 2015

1957-25 Metagenics_HIfCN-logo_color-01_websizeMetagenics Healthcare Institute for Clinical Nutrition (www.mhicn.com) announced that the 75th anniversary of the American Diabetes Association’s (ADA) included a presentation on June 6, 2015 by Osama Hamdy, MD, PhD on new clinical evidence on use of a novel medical food (Ultra Glucose Control™ by Metagenics) for management of glucose response. Dr. Hamdy is Medical Director at Joslin Diabetes Center, Assistant Prof. of Medicine at Harvard Medical School and principal investigator for the study. The study was a clinical comparison of 3 diabetes specific formulas (Ultra Glucose Control™[UGC], another commercial product and regular oatmeal) on glucose metabolism and read more…

© 2017 Modern Healthcare Professional. All Rights Reserved.